Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Schizophrenia Treatment: During Pregnancy & Postpartum- Update
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psychiatry In Depth
Page 1 of 1
Schizophrenia Treatment: During Pregnancy & Postpartum- Update
Schizophrenia Treatment: During Pregnancy & Postpartum- Update
Source: J Popul Ther Clin Pharmacol Vol 19(3):e380-e386; 2012
ANTIPSYCHOTICS
Typical AntipsychoticsSource: J Popul Ther Clin Pharmacol Vol 19(3):e380-e386; 2012
ANTIPSYCHOTICS
* Teratogenesis:
- no increase in teratogenesis in women taking piperidyl phenothiazines (thioridizine), piperazines (fluphenazine, perphenazine), phenothiazines (chlorpromazine, promethazine), piperazine phenothiazines (trifluoperazine), butyrophenones (haloperidol), thioxanthenes (flupenthixol), dibenzoxazepines or diphenylbutylpiperidines.
* Labour and Delivery:
- Those exposed to typical antipsychotics during pregnancy had a significantly lower mean birth weight and a higher incidence of small for gestational age infants (?? not consistent among other studies)
* Effects on the Neonate:
-Chlorpromazine, Flupenthixol and Fluphenazine have been associated with a risk of neonatal withdrawal and extrapyramidal signs that may last for weeks to months.
- Use of promethazine in late pregnancy could induce respiratory distress in the newborn and impaired platelet aggregation in the mother and the newborn.
* Long-Term Effects:
- No differences have been found in behavior, socialization or cognition in nine and ten year olds who were exposed to chlorpromazine in utero.
Atypical Antipsychotics
* Teratogenesis:
- There is no conclusive evidence of an increased risk of teratogenesis.
- There may, however, be an indirect risk; the use of atypicals during pregnancy may lead to weight gain that, in turn, can increase the risk for neural tube defects, hypertension, pre-eclampsia and gestational diabetes.
* Labour and Delivery:
- Exposure to atypical antipsychotics during pregnancy did not cause an increased risk for adverse pregnancy outcomes.
* Effects on the Neonate:
- Infants exposed to atypical antipsychotics had a significantly higher incidence of large for gestational age.
- Increased risk of hypoglycaemia and macrosomia resulting in shoulder dystocia and associated birth injuries such as fractures and nerve palsies.
* Long-Term Effects:
- Normal development has been reported in the offspring of women taking atypical antipsychotics
in pregnancy.
ANTICHOLINERGICS
- Little researched but may be teratogenic and are best avoided in pregnancy
ANTIDEPRESSANTS
- May cause a small increase in miscarriage risk but
- Do not appear to cause an increase in major malformations.
BENZODIAZEPINES
- No increases in malformations have been reported with lorazepam, clonazepam, alprazolam, triazolam or flurazopam.
- Withdrawal syndromes may be seen after use of clonazepam, alprazolam, and lorazepam.
- Lorazepam used in late pregnancy may lead to respiratory distress, decreased APGARS, problems with temperature regulation and poor feeding.
- No malformations or delivery problems have been reported with zopiclone use but
- Low birth weight, preterm deliveries and small for gestational age babies have been found after the use of zopildem.
Similar topics
» The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter?
» possible treatment-research into antibiotic and schizophrenia
» Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment?
» 2013 Update: CANMAT & ISBD Update on Bipolar Disorder Management
» Schizophrenia Discussion Thread.
» possible treatment-research into antibiotic and schizophrenia
» Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment?
» 2013 Update: CANMAT & ISBD Update on Bipolar Disorder Management
» Schizophrenia Discussion Thread.
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psychiatry In Depth
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin